Estradiol

Basic Information

Item Value
DrugBank ID DB00783
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 23

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 symptomatic form of fragile X syndrome in female carrier KG + DL
2 anovulation KG + DL
3 ovarian remnant syndrome KG + DL
4 partial trisomy/tetrasomy of the short arm of chromosome 18 KG + DL
5 partial trisomy/tetrasomy of the short arm of chromosome 12 KG + DL
6 partial trisomy/tetrasomy of the short arm of chromosome 5 KG + DL
7 blepharophimosis-epicanthus inversus-ptosis due to 3q23 rearrangement syndrome KG + DL
8 luteoma of pregnancy KG + DL
9 partial autosomal trisomy/tetrasomy KG + DL
10 ovarian ectopic pregnancy KG + DL
11 blepharophimosis-epicanthus inversus-ptosis KG + DL
12 ovarian dysfunction KG + DL
13 zinc, elevated plasma KG + DL
14 stapes ankylosis with broad thumbs and toes KG + DL
15 telecanthus KG + DL
16 ovarian hyperstimulation syndrome KG + DL
17 sebaceous gland anomaly KG + DL
18 pyogenic arthritis-pyoderma gangrenosum-acne syndrome KG + DL
19 46,XY disorder of sex development due to testicular steroidogenesis defect KG + DL
20 lateral medullary syndrome KG + DL
21 transverse vaginal septum KG + DL
22 longitudinal vaginal septum KG + DL
23 female infertility KG + DL

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). 本報告僅供研究參考,不構成醫療建議。

This site uses Just the Docs, a documentation theme for Jekyll.